Annual Drug Patent Expirations for GALAFOLD
Galafold is a drug marketed by Amicus Theraps Us and is included in one NDA. There are twenty-one patents protecting this drug.
This drug has one hundred and eight patent family members in twenty-six countries.
The generic ingredient in GALAFOLD is migalastat hydrochloride. Additional details are available on the migalastat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
